Liver Fibrosis (DBCOND0030052)

Identifiers

Synonyms
Fibrosis, Liver / Fibrosis of Liver / Hepatic fibrosis, unspecified / Hepatic fibrosis / Fibrosis liver / Hepatic fibrosis (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03548597
Evaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT06315361
DIAbetes and NAFLDNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05402371
A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosistreatment2active_not_recruiting
NCT05473806
Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetestreatment4unknown_status
NCT04442334
The European NAFLD RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT05651724
Global Research Initiative for Patients Screening on MASHNo drug interventionsNot AvailableNot Availablerecruiting
NCT03373396
Impact of Chlordecone on Active Chronic HepatitisNo drug interventionsdiagnosticNot Availablecompleted
NCT06519448
Reducing Non-Alcoholic SteatohepatitistreatmentNot Availableenrolling_by_invitation
NCT05120557
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASHNo drug interventionsdiagnosticNot Availableunknown_status
NCT04493762
Liver Fibrosis and Gut Microbiota in Patients With Psoriasis Vulgaris and Rheumatoid Arthritis on MethotrexateNo drug interventionsNot AvailableNot Availableunknown_status
NCT02344680
Liver Fibrosis in Zambian HIV-HBV Co-infected PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06248580
Find HDV and Determine Its Status in TurkeyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06564740
Stem Cell Applications in Biliary Atresia PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT05196867
Liver Cancer Prevention Randomized Control TrialNo drug interventionspreventionNot Availablerecruiting
NCT02569567
Comparison of Smart-Shear Wave Elastography and Transient ElastographyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03222167
Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1btreatment3unknown_status
NCT03656068
An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosisbasic_science2completed
NCT06005012
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DMtreatment2recruiting
NCT04480710
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjectstreatment2completed
NCT05567614
Platelets Indices and Its Role to Predict Liver Fibrosis in Patients With Chronic Hepatitis B InfectionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06463223
HIBOC = Hepatic Imaging Biomarkers in Obese ChildrenNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02682108
Diffusion-weighted Imaging Magnetic Resonance for Assessing Liver FibrosisNo drug interventionsdiagnosticNot Availablecompleted
NCT04620538
Volatile Organic Compounds for the Assessment of Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT05218538
Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records.No drug interventionsNot AvailableNot Availableunknown_status
NCT05147090
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis Btreatment4recruiting
NCT04759521
Evaluation of Liver Fibrosis With 2D-Shear Wave ElastographyNo drug interventionsNot AvailableNot Availablecompleted
NCT03492879
Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases SeverityNo drug interventionsdiagnosticNot Availableunknown_status
NCT04380493
The Use of the Transient Elastography Paediatric Probe, Compared to the M Probe, Indirect Biomarkers and HistologyNo drug interventionsNot AvailableNot Availablecompleted
NCT06293378
Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis.treatmentNot Availablerecruiting
NCT06111859
Effectiveness of Ultrasound in Liver Stiffness and Fat QuantificationNo drug interventionsdiagnosticNot Availablerecruiting
NCT03158818
Chronic Hepatitis B Virus Infection in ZambiaNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05692024
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCERNo drug interventionsprevention1 / 2recruiting
NCT03659058
Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVRtreatmentNot Availablecompleted
NCT06366425
Screening for Chronic Liver Diseases in General PopulationNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT04595474
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 DiabetesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05855031
The Liver Care TrialNo drug interventionsscreeningNot Availablerecruiting
NCT04175392
Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitistreatment1 / 2terminated
NCT04493346
Shear Wave ElastographyNo drug interventionsNot AvailableNot Availablecompleted
NCT00006164
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatmentprevention3completed
NCT05479721
LITMUS Imaging StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03173287
Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRINo drug interventionsdiagnosticNot Availableunknown_status
NCT02922751
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)No drug interventionsNot AvailableNot Availablecompleted
NCT03277651
Noninvasive Diagnostic Platform for Liver Fibrosis and Portal HypertensionNo drug interventionsNot AvailableNot Availableunknown_status
NCT01988753
Non-invasive Biomarkers of Fibrosis in Pediatric Liver DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT01934777
Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitistreatment3completed
NCT00956098
Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosistreatment2completed
NCT03176797
Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRINo drug interventionsdiagnosticNot Availableenrolling_by_invitation
NCT05224128
Effect of Imatinib in Advance Liver Fibrosis Patientstreatment1 / 2unknown_status
NCT04533828
68Ga-FAPI PET/CT in Liver Fibrosis PatientsNo drug interventionsdiagnostic0unknown_status
NCT00151671
Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver CancerNo drug interventionsprevention2 / 3terminated
NCT03568578
A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding BiomarkersdiagnosticNot Availableunknown_status
NCT05490888
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhoticstreatment1recruiting
NCT03896607
Liver and the Spleen Stifness in Adult Patients With Gaucher's Disease Using Ultrasound Shear Wave ElastographyNo drug interventionsNot AvailableNot Availableterminated
NCT04099407
Pirfenidone and Advanced Liver Fibrosis.treatment2completed
NCT06063785
Multispectral Optoacoustic Tomography in Patients With Cystic FibrosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT01231685
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infectiontreatment2completed
NCT06144437
Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of GOV in Patients With cACLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT02181452
Liver Fibrosis Assessment With ShearWave ElastographyNo drug interventionsNot AvailableNot Availablecompleted
NCT05435599
Serum Regucalcin Level and Chronic Hepatitis BNo drug interventionsdiagnosticNot Availablecompleted
NCT05305599
Different Doses of ZED1227 vs. Placebo in NAFLDtreatment2completed
NCT02313649
ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis BNo drug interventionsNot AvailableNot Availablecompleted
NCT01825213
Stratification of Patients With Chronic Liver Disease Using Multi Spectral CTNo drug interventionsNot AvailableNot Availablecompleted
NCT00885313
Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)treatment1 / 2completed
NCT01965418
A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical TrialNo drug interventionstreatment4unknown_status
NCT06098417
Biomarkers in the Diagnosis and Prognosis of NAFLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT06147934
Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT01311934
Visceral Stiffness Measurement Using Acoustic Radiation Force ImpulseNo drug interventionsNot AvailableNot Availableunknown_status
NCT03872024
Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT00926224
Fibroscan® and Its Dedicated Probes Efficiency in Obese PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT01810458
Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)Not AvailableNot Availablecompleted
NCT00777725
Non-invasive Assessment of Liver Stiffness/Fibrosis by Transient Elastography (Fibroscan) in Patients With Left and/or Right Sided Heart FailureNo drug interventionsNot AvailableNot Availablecompleted
NCT03608748
Early Detection of Advanced Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT03539757
Development of Novel MRI Methods for Detecting, Discriminating, and Measuring Liver Fibrosis and Congestion in Fontan PatientsNo drug interventionsNot AvailableNot Availableterminated
NCT04908657
Sildenafil for Liver Fibrosis in Adolescents and Adults After Fontan Operationtreatment4unknown_status
NCT06308757
Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With FibrosisNo drug interventionstreatmentNot Availablerecruiting
NCT02603666
Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic AspectsNo drug interventionsdiagnosticNot Availablecompleted
NCT01537965
Evaluation of Innovative Ultrasonic Techniques for Non-invasive Diagnosis of Liver Fibrosis in Patients With Chronic Viral Hepatitis B or CNo drug interventionsdiagnosticNot Availablecompleted
NCT03919565
Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver FibrosistreatmentNot Availableunknown_status
NCT01268865
Acoustic Radiation Force Impulse (ARFI)Technology in Prediction of Liver FibrosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00180674
Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infectiontreatment2completed
NCT05168982
Development of Non-Invasive MRI Applications for Liver Fibrosis and InflammationNo drug interventionsNot AvailableNot Availablerecruiting
NCT02372682
Shear Wave Sonoelastography in Pediatric Liver FibrosisNo drug interventionsNot AvailableNot Availablecompleted
NCT03342560
Beyond Confounders: Addressing Source of Measurement Variability and Error in Shear Wave ElastographyNo drug interventionsdiagnosticNot Availablecompleted
NCT05239260
Impact of Fluid Status on Liver Elastography and T1-mapping Results in Patients Undergoing CMR.No drug interventionsNot AvailableNot Availableunknown_status
NCT06267794
Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis.treatment2completed
NCT03908294
Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral AgentsNo drug interventionsNot AvailableNot Availablecompleted
NCT05180162
Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286No drug interventionsdiagnostic1recruiting
NCT06364462
Precise Evaluation Criteria for Histological Regression of NASH FibrosisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02060162
Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern AfricaNo drug interventionsNot AvailableNot Availablecompleted
NCT03957629
Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver FibrosistreatmentNot Availableunknown_status
NCT05526144
Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veteranstreatment2recruiting
NCT02353767
Evaluation of Liver Fibrosis in HIV-infected Patients With Metabolic SyndromeNo drug interventionsNot AvailableNot Availablecompleted
NCT00323804
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.treatment2 / 3completed
NCT05974904
Association of hsCAR With MAFLD and Liver Fibrosis: A Cross-sectional StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01707472
Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosistreatment2completed
NCT01260012
Antioxidant Supplements in the Reversal of Schistosomal Peri-portal FibrosisNo drug interventionstreatmentNot Availableunknown_status
NCT02348814
Development of a Novel Biomarker for Liver FibrosisNo drug interventionsNot AvailableNot Availablecompleted
NCT01962155
Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive ParametersNo drug interventionsNot AvailableNot Availablecompleted
NCT06244550
Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic FactorstreatmentNot Availablecompleted
NCT01781208
Ultrasound Based Acoustic Radiation Force Impulse ImagingNo drug interventionsdiagnosticNot Availablecompleted
NCT04573543
The Role of Immune Semaphorins in NAFLDNo drug interventionsNot AvailableNot Availablecompleted
NCT04895943
Bariatric Endoscopy and NAFLDNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03386890
Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver FibrosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT06138821
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled TrialNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00941902
A Potential Novel Marker for Liver Fibrosis in NASH: the Soluble Secreted Form of the Human Asialoglycoprotein ReceptorNo drug interventionsNot AvailableNot Availablecompleted
NCT05525884
Mechanism of Serum PRL in the Development of MAFLDNo drug interventionsNot AvailableNot Availableunknown_status
NCT01133184
Improved Prevention of Perinatal Hepatitis B TransmissionNo drug interventionsprevention4unknown_status
NCT00896233
Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED)No drug interventionsdiagnostic1completed
NCT02021253
Influence of Probiotics Administration Before Liver Resection in Liver DiseaseNo drug interventionsotherNot Availablecompleted
NCT03293953
Prospective Comparison Between TE, SWE and MRE (FULLFIBRO01)No drug interventionsNot AvailableNot Availableunknown_status
NCT02138253
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCVtreatment2completed
NCT04971577
Efficacy of Simvastatin in Alcoholic Liver Fibrosistreatment2 / 3recruiting
NCT05262647
18F-FAPI PET in the Diagnosis of Liver FibrosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT06147947
Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT03920605
Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver FibrosistreatmentNot Availableunknown_status
NCT05308628
Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis PanelNo drug interventionsscreeningNot Availablerecruiting
NCT05926778
Multiomics Study of Fibrosis Factors After Liver Transplantation and Exploration of Fibrosis Methylation BiomarkersNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05935488
Early Liver Disease Breath DetectionNo drug interventionsNot AvailableNot Availablerecruiting
NCT05506488
Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Diseasetreatment1 / 2recruiting
NCT02165488
Frequent Ketamine Use and Gastrointestinal, Liver and Biliary SequelaeNo drug interventionsNot AvailableNot Availablecompleted
NCT05154656
Three-Dimensional T1rho Using Spiral Fast Spin EchoNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05383456
The Visceral Adiposity Measurement and Observation StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05224037
Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouchNo drug interventionsdiagnosticNot Availablecompleted
NCT04857437
Study in Healthy Adults Evaluating PF-07202954No drug interventionsbasic_science1completed
NCT02289300
A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer PatientsNo drug interventionstreatment2withdrawn
NCT04429100
Rapid Breath-hold Quantitative Macromolecular Proton Fraction Imaging for Liver FibrosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03637959
Liver Fibrosis Evaluation Using Ultrasound Shear Wave ImagingNo drug interventionsotherNot Availablecompleted
NCT06374875
Fibrosis Lessens After Metabolic SurgeryNo drug interventionstreatment4recruiting
NCT04669470
Bariatric Endoscopy and NAFLDNo drug interventionstreatmentNot Availableunknown_status
NCT05602870
Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric UnitNo drug interventionspreventionNot Availablecompleted
NCT03957070
The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and SteatosisNo drug interventionsdiagnosticNot Availablecompleted
NCT00049842
Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)treatment3completed
NCT05115942
Hydronidone for the Treatment of Liver Fibrosis Associated With Chronic Viral Hepatitis B Phase 3 Trial.treatment3recruiting
NCT03486899
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosistreatment2completed
NCT01341106
Induction of Fibrosis Regression on Patients With Chronic Hepatitis B InfectionNot Available4terminated
NCT04146636
Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (IMPROVE Study)No drug interventionsdiagnosticNot Availablecompleted
NCT01454336
Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With PioglitazoneNo drug interventionstreatment1completed
NCT05699018
Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic PatientsNo drug interventionsscreeningNot Availablerecruiting
NCT01082419
Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver ElasticityNo drug interventionsdiagnosticNot Availablecompleted
NCT00119119
Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis Ctreatment3terminated
NCT04168619
MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic ToolNot AvailableNot Availableunknown_status
NCT05644717
Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLDtreatment4not_yet_recruiting
NCT01935817
Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBVtreatment3completed
NCT04605939
Clinical Application of Fibroblast Activation Protein PET/MRI in Liver FibrosisNo drug interventionsdiagnosticNot Availablerecruiting
NCT03479125
Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or PlaceboNo drug interventionsNot AvailableNot Availableterminated
NCT03863730
Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic MicrobiotaNo drug interventionspreventionNot Availableactive_not_recruiting
NCT01757730
Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft TissuesNo drug interventionsNot AvailableNot Availablerecruiting
NCT06509230
Prediction of Significant Liver FibrosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04747457
Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE ExaminationNo drug interventionsotherNot Availablecompleted
NCT00326482
Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral TherapyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01241227
Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT03623360
Functional MRI to Determine Severity of CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT05817994
Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure RegistryNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03663062
ObeSity Related Colorectal Adenoma RiskNo drug interventionsNot AvailableNot Availablecompleted
NCT02041780
Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liver BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT04640129
HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.treatment4recruiting
NCT05486767
Screening of Liver Fibrosis in Adults Without Known Liver DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT02174367
An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe PsoriasisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00673101
Prospective Evaluation of FibroScan in Patients Treated With MethotrexateNo drug interventionsNot AvailableNot Availablecompleted
NCT04561804
NAFLD and Liver Fibrosis in Obese AdolescentsNo drug interventionsNot AvailableNot Availablecompleted
NCT05905172
Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosistreatment3recruiting
NCT03420768
A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis CNo drug interventionstreatment2completed
NCT06051669
Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the USNo drug interventionsNot AvailableNot Availablerecruiting
NCT00453869
Screening of Fibrosing and/or Viral Chronic Hepatopathies in JailNo drug interventionsNot AvailableNot Availableterminated
NCT03486912
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosistreatment2completed
NCT01938781
Optimized Treatment and Regression of HBV-induced Liver Fibrosistreatment4completed
NCT02476695
FibroTouch Non-invasive Evaluation of Liver Fibrosis and CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00298714
Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis Ctreatment4completed
NCT03445208
A Study of Experimental Medication BMS-986036 Given to Healthy Participantstreatment1completed
NCT01789008
Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.No drug interventionsdiagnosticNot Availablecompleted
NCT01452308
Pilot Study of Simtuzumab in the Treatment of Liver Fibrosistreatment2completed
NCT05457543
Blood Collection for Development and Validation of Point-of-Care Diagnostic Liver Function TestsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05154643
T1rho Imaging of Liver in Presence of IronNo drug interventionsNot AvailableNot Availablecompleted
NCT05560503
A Nomogram for Evaluating Significant Liver Fibrosis in Patients With Chronic Hepatitis B Virus InfectionNo drug interventionsNot AvailableNot Availablecompleted
NCT00043303
Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosistreatment2completed
NCT01572064
Magnetic Resonance Imaging in the Evaluation of Liver FibrosisNo drug interventionsdiagnosticNot Availablecompleted
NCT01981421
Usefulness of Multi-parametric, Quantitative MR Imaging for Staging of Hepatic Fibrosis in the Patients With Chronic HepatitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT01072721
Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic FibrosisNo drug interventionsdiagnosticNot Availablecompleted
NCT05912179
Prospective Single Centre Observational Study to Compare the Diagnostic Yield of Different Modalities of Liver BiopsyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02206841
Establishment of NAFLD Cohort and Development of Fibrosis MarkersNo drug interventionsNot AvailableNot Availablerecruiting
NCT01390194
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablecompleted